DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

Ibuprofen

To Patients

To Patients

Therapeutic Approach

Anti-Inflammatory

Ibuprofen is an oral, non-steroidal, anti-inflammatory medication.

Status

A four-year high dose ibuprofen trial completed in 1994 demonstrated less lung function decline in the treatment group than the control group. The effect was more pronounced in people with CF who were younger than age 13 when they started the trial. 

Sponsor

In the US, the program was funded by the Cystic Fibrosis Foundation.

Contact us about Ibuprofen >